Answers are grounded in this paper and cite their sources.
Background. Adrenocortical carcinoma (ACC) is a rare, aggressive malignant tumor of the adrenal cortex. The biological heterogeneity of ACC accounts for a wide range of clinical outcomes, even within the same stage. In addition to anatomical extent, prognosis is influenced by mitotic activity, resection margin status, age, the presence of symptoms, and autonomous cortisol secretion. Consequently, modern risk assessment is shifting from the analysis of single parameters toward integrated models such as the S-GRAS score, which incorporate tumor stage, grade, completeness of resection, age, and symptoms. The purpose of the study was to improve the outcomes of surgical treatment in patients with ACC by identifying factors influencing long-term survival. Materials and methods. A retrospective analysis was performed of 102 patients with ACC who underwent surgery at the clinic of the V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine between 2002 and 2022. The analysis included sex, age, tumor size, hormonal activity, T, N, and M categories, surgical approach, and calendar period of surgery. Survival was estimated using the Kaplan-Meier method, and survival curves were compared using the log-rank test. Results. The 5-year overall survival rate was 54 %, and the 10-year rate was 48 %. Survival was higher in T1-T2 than in T3-T4 (p < 0.005), in N0 than in N1 (p < 0.001), and in M0 than in M1 (p < 0.005). Increasing tumor size was associated with a worse prognosis; the difference was statistically significant at a threshold of 70 mm (p < 0.001). No difference was found between hormonally inactive tumors and tumors associated with Cushing’s syndrome (p = 0.900). Conclusions. The main adverse factors affecting long-term survival were local tumor extension, regional lymph node involvement, distant metastases, and tumor size greater than 70 mm. Laparoscopic adrenalectomy may be considered only in carefully selected patients without evidence of invasive tumor growth or metastatic involvement of retroperitoneal lymph nodes.
No takes yet. Share an insight, caveat, or question.
Bolgov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: